Get the Stockscreener App
2.31
2.43%
0.05
Werewolf Therapeutics Inc stock is traded at $2.31, with a volume of 294.09K.
It is up +2.43% in the last 24 hours and up +14.04% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$2.26
Open:
$2.21
24h Volume:
294.09K
Relative Volume:
0.52
Market Cap:
$101.39M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-1.8189
EPS:
-1.27
Net Cash Flow:
$-33.38M
1W Performance:
-14.89%
1M Performance:
+14.04%
6M Performance:
-61.86%
1Y Performance:
-26.97%
1-Day Range:
$2.20
$2.33
1-Week Range:
$2.20
$2.87
52-Week Range:
$1.66
$8.1939
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Werewolf Therapeutics announces IL-10 Indukine development candidate for inflammatory bowel disease - BioWorld Online
Werewolf Therapeutics expands pipeline with new IBD candidate - Investing.com
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024 - The Manila Times
Werewolf Therapeutics Announces Promising New Development - GlobeNewswire
Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINE™ Molecule for Inflammatory Diseases - StockTitan
WisdomTree Inc (NYSE: WT): Blank Check On Growth? - Stocks Register
Werewolf To Provide Clinical Update On WTX-330 - RTTNews
Werewolf Therapeutics Inc (NASDAQ: HOWL) Could Pass $12 In One Year Stock Forecast - Stocks Register
Social Security Just Released the 2025 COLA. Here's What It Means for Those Receiving Spousal Benefits. - Yahoo! Voices
Could Buying Apple Stock Today Set You Up for Life? - Yahoo! Voices
Is Summit Therapeutics Inc. (SMMT) the Best QQQ Stock to Buy According to Analysts? - Yahoo Finance
Lyft is working on a ‘service animal opt-in feature’ for passengers - Yahoo! Voices
Hammond packaging facility to get $35M upgrade - Yahoo! Voices
2 Game-Changing Artificial Intelligence (AI) Stocks to Buy Right Now (Hint: Not Nvidia) - Yahoo! Voices
Poland’s stunning success should be discomforting for Britain - Yahoo! Voices
Every UPS Investor Should Keep an Eye on This Number - Yahoo! Voices
Billionaire Philippe Laffont Just Increased His Position by 139% in This Data Center Opportunity (Hint: It's Not Nvidia) - Yahoo! Voices
We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate - Yahoo Finance
ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year - Yahoo Finance
Bank of America Predicts up to ~390% Surge for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Cut the state to get growing - Yahoo! Voices
‘It’s huge’: Striking Boeing workers near deal - Yahoo! Voices
National Association of Black Accountants’ St. Louis Chapter honors 50 years of community impact - Yahoo! Voices
Voya Financial Reports $341 Billion AUM Milestone - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
mRNA licensing agreements surge 800% amid GSK lawsuits - Yahoo Finance
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc - Yahoo Finance
State Street Corp's Strategic Reduction in Viking Therapeutics Holdings - Yahoo Finance
Nvidia to be the first company to hit $4T market cap: Lumida CEO - Yahoo Finance
LGT incorporates its Barcelona digital hub - Yahoo News
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar? - Yahoo Finance
Millennium Management LLC's Strategic Reduction in Esperion Therapeutics Inc Holdings - Yahoo Finance
NantHealth (NASDAQ:NH) Coverage Initiated by Analysts at StockNews.com - Defense World
StockNews.com Downgrades Nomad Foods (NYSE:NOMD) to Hold - Defense World
Microsoft said it lost weeks of security logs for its customers' cloud products - Yahoo! Voices
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - Yahoo Finance
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc - Yahoo Finance
Walgreens has more than 100 stores in Indiana. Company plans to shut down 1,200 nationwide - Yahoo News
Dogwood Therapeutics, Inc. Expected to Earn Q3 2024 Earnings of ($1.40) Per Share (NASDAQ:DWTX) - Defense World
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug - Yahoo Finance
AQR Capital Management LLC Has $331,000 Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
6,661 Shares in Fortune Brands Innovations, Inc. (NYSE:FBIN) Acquired by Sanctuary Advisors LLC - Defense World
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce - Yahoo Finance
Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment - Yahoo Finance
Power Co. of Canada (TSE:POW) Receives C$43.28 Average Target Price from Brokerages - Defense World
AQR Capital Management LLC Makes New Investment in Canadian Natural Resources Limited (NYSE:CNQ) - Defense World
Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion - Yahoo Finance
Wells Fargo & Company Increases AptarGroup (NYSE:ATR) Price Target to $185.00 - Defense World
Q4 2025 Earnings Estimate for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Issued By Zacks Research - Defense World
London Stock Exchange Group (LON:LSEG) Trading 0.6% Higher – Here’s What Happened - Defense World
Finward Bancorp (OTCMKTS:FNWD) Trading Down 1% – Time to Sell? - Defense World
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):